Prognostic impact of microvascular dysfunction and systemic inflammation in women with chronic heart failure
The combined assessment of coronary microvascular function and inflammatory biomarkers independently predicts adverse outcomes and improves risk stratification beyond conventional markers and highlights the importance of the inflammation–microvascular axis in heart failure pathophysiology in women.